Jasmin Bartl

Jasmin Bartl

Auto-generated profile, based on publicly available information

Jasmin Bartl

Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Würzburg, Germany

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2012 in The World Journal of Biological Psychiatry
Verified
Journal Article
Closed access
JBJasmin Bartl
Jasmin Bartl
CMCamelia-Maria Monoranu
Camelia-Maria Monoranu
AWAnne-Kristin Wagner
Anne-Kristin Wagner
JKJann Kolter
Jann Kolter
PRPeter Riederer
Peter Riederer
EGEdna Grünblatt
Edna Grünblatt
OBJECTIVES: Although Alzheimer's disease (AD) is the most common form of dementia in the elderly, its aetiology remains mostly unknown. A potential pathophysiological mechanism for AD arises from the knowledge that insulin is also synthesized independently in the central nervous system and is involved in the regulation of memory formation. AD may represent a brain-specific form of insulin resistance.\ud METHODS: We used immunohistochemistry to investigate the numbers of cells expressing insulin receptor β-subunit (IRβ) and phosphorylated PPARγ (PPARγ(p)) in human post-mortem tissue from patients with AD; AD combined with type 2 diabetes mellitus (T2DM); just T2DM , and from aged-matched controls. These numbers were evaluated in frontal cortex and in dorsal/ventral parts of the hippocampus.\ud RESULTS: We observed significantly lower numbers of IRβ positive cells in AD cases compared to all other groups in all investigated brain regions. Also significantly more PPARγ(p) positive cells occurred in each patient group compared to control.\ud CONCLUSIONS: T2DM and AD may not be directly linked, but may share common histological features including lower numbers of IRβ positive cells and higher numbers of PPARγ(p) positive cells in all investigated brain regions. These observations may at least partially explain the increased frequency of AD in elderly diabetic patients

11 July 2012 in Journal of Neural Transmission
Verified
Journal Article
Closed access
PDF file
JBJasmin Bartl
Jasmin Bartl
AMAndrea Meyer
Andrea Meyer
SBSvenja Brendler
Svenja Brendler
PRPeter Riederer
Peter Riederer
EGEdna Grünblatt
Edna Grünblatt

22 November 2011 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
JBJasmin Bartl
Jasmin Bartl
CSClaus-Jürgen Scholz
Claus-Jürgen Scholz
MHMargareta Hinterberger
Margareta Hinterberger
SJSusanne Jungwirth
Susanne Jungwirth
IWIldiko Wichart
Ildiko Wichart
EGEdna Grünblatt
Edna Grünblatt
Insulin-degrading enzyme (IDE) is the ubiquitously expressed enzyme responsible for insulin and amyloid beta (Aβ) degradation. IDE gene is located on chromosome region 10q23-q25 and exhibits a well-replicated peak of linkage with Type 2 diabetes mellitus (T2DM). Several genetic association studies examined IDE gene as a susceptibility gene for Alzheimer's disease (AD), however with controversial results.